Skip to content
Daniel Chen, Founder and CEO at Synthetic Design Lab episode artwork

Jun 15, 2026 53 min

Daniel Chen, Founder and CEO at Synthetic Design Lab

from Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere Hosted by Jesús E. Moreno

In this episode of Global Trial Accelerators, we speak with Daniel S. Chen, MD, PhD, Founder and CEO of Synthetic Design Lab and former Global Head of Cancer Immunotherapy Development at Genentech/Roche. Daniel shares insights from his pioneering work in cancer immunotherapy, the development of breakthrough therapies such as atezolizumab, and the future of oncology innovation. We also discuss the Cancer-Immunity Cycle, translational science, and what it takes to accelerate the path from discovery to patient impact.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Daniel Chen, Founder and CEO at Synthetic Design Lab

0:00 53:35

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere?

This episode is 53 minutes long.

When was this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode published?

This episode was published on June 15, 2026.

Can I download this Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.